Today’s top gainers include the company Incyte Corporation (NASDAQ:INCY) which is in the industry Biotechnology, gaining 1.21% today. In the last week its performance is 5.23%, and 10.69% for the past quarter. Currently, Incyte Corporation, INCY has a target price of 92.43, so today’s gain of 1.21% is a significant step towards its target price. The GAP today is therefore 0.35%.
Incyte Corporation (NASDAQ:INCY), has a market cap of 16262.55, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 98.90%.
At the current price of 87.93, it has a dividend yield of *TBA, and its target price is 92.43. This is with a profit margin of 5.70%, and total debt/equity of 0. Incyte Corporation (NASDAQ:INCY) has a P/E of 411.75, as well as a forward P/E of 63.84.
With a current EPS of 0.21, and a forecasted EPS growth for next year at 2924.44%,Incyte Corporation (NASDAQ:INCY) has had a EPS growth for the past five years at 16.40%. For the next five years EPS growth is projected to be 38.70%.
Performance for the year is -23.70%. Since its IPO date on 11/4/1993, the total performance to date is -19.89%.
Volume today for Incyte Corporation (NASDAQ:INCY), is 770921, while its average volume is 1094.12. Whilst the total gain today was 1.21%, it did have a day high of 0.06%.
Volatility for this week has been at 2.99%, and 3.98% for the month. The 52-week low for Incyte Corporation, INCY has been 59.87%, while the 52-week-high has reached -34.19%.
Looking at its return of investments, which is 6.30%, and its return on assets is 4.90%. Incyte Corporation (NASDAQ:INCY) has an operating margin of 10.90%. With a sales growth of 65.40% quarter over quarter. Bearing in mind that Incyte Corporation, INCY is in the sector Healthcare, its long-term debt/equity is 2.76, and has a current ratio of 4.7 and 4.7 for quick ratio.
So what is the value of Incyte Corporation? Well its PEG is 10.64, and the P/S is 18.96, along with a P/B of 71.21. Meanwhile it has a p/cash of 20.06.